Total Payments
$29,260
2024 Payments
$3,418
Companies
61
Transactions
879
Medicare Patients
3,038
Medicare Billing
$462,134
Payment Breakdown by Category
Food & Beverage$21,784 (74.4%)
Consulting$4,550 (15.6%)
Travel$2,859 (9.8%)
Education$67.48 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,784 | 860 | 74.4% |
| Consulting Fee | $4,550 | 1 | 15.6% |
| Travel and Lodging | $2,859 | 13 | 9.8% |
| Education | $67.48 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nuvectra Corporation | $5,587 | 12 | $0 (2018) |
| Boston Scientific Corporation | $4,517 | 79 | $0 (2024) |
| Nevro Corp. | $2,965 | 27 | $0 (2021) |
| Medtronic Vascular, Inc. | $2,233 | 30 | $0 (2020) |
| Medtronic, Inc. | $1,892 | 43 | $0 (2024) |
| Abbott Laboratories | $1,591 | 40 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $893.73 | 57 | $0 (2024) |
| Daiichi Sankyo Inc. | $816.50 | 52 | $0 (2019) |
| Egalet US Inc | $783.73 | 82 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $779.72 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,418 | 68 | Boston Scientific Corporation ($1,693) |
| 2023 | $1,224 | 45 | Boston Scientific Corporation ($496.22) |
| 2022 | $1,905 | 63 | Abbott Laboratories ($711.77) |
| 2021 | $2,080 | 60 | Medtronic, Inc. ($897.41) |
| 2020 | $1,612 | 71 | Boston Scientific Corporation ($455.62) |
| 2019 | $3,002 | 149 | Nevro Corp. ($682.53) |
| 2018 | $10,977 | 223 | Nuvectra Corporation ($4,996) |
| 2017 | $5,042 | 200 | Medtronic Vascular, Inc. ($1,655) |
All Payment Transactions
879 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Neuromodulation | ||||||
| 12/03/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $81.85 | General |
| Category: Not Applicable | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.38 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.83 | General |
| Category: Opioid Analgesic | ||||||
| 10/10/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Not Applicable | ||||||
| 10/02/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: EndoVenous Therapies | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $123.66 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/18/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: EndoVenous Therapies | ||||||
| 09/13/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | BIOTRONIK NRO, Inc. | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 08/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $182.97 | General |
| Category: General - Therapies_NMD | ||||||
| 08/23/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $221.27 | General |
| Category: General - Therapies_NMD | ||||||
| 08/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $142.93 | General |
| Category: General - Therapies_NMD | ||||||
| 08/23/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $50.90 | General |
| Category: General - Therapies_NMD | ||||||
| 07/30/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $39.59 | General |
| Category: Pain Management | ||||||
| 07/30/2024 | BIOTRONIK NRO, Inc. | — | Food and Beverage | In-kind items and services | $5.74 | General |
| 07/29/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Opioid Analgesic | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: Opioid Analgesic | ||||||
| 07/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Analgesic | ||||||
| 07/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $105.80 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $6.33 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 995 | 1,832 | $722,577 | $158,049 |
| 2022 | 12 | 781 | 1,372 | $208,149 | $114,812 |
| 2021 | 9 | 298 | 492 | $79,196 | $36,899 |
| 2020 | 20 | 964 | 2,047 | $805,787 | $152,374 |
Total Patients
3,038
Total Services
5,743
Medicare Billing
$462,134
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 529 | $63,417 | $29,872 | 47.1% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 27 | 33 | $244,011 | $29,659 | 12.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 160 | 438 | $50,663 | $26,193 | 51.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 34 | 63 | $19,800 | $9,515 | 48.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 93 | 93 | $18,717 | $7,663 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 86 | $14,708 | $7,555 | 51.4% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2023 | 69 | 81 | $6,350 | $5,954 | 93.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 46 | 53 | $15,950 | $5,943 | 37.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 26 | 27 | $42,272 | $5,805 | 13.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 33 | 54 | $39,727 | $5,322 | 13.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 44 | 54 | $57,314 | $3,985 | 7.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 24 | 31 | $27,718 | $3,250 | 11.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 33 | 54 | $17,801 | $3,011 | 16.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 14 | 21 | $18,439 | $2,403 | 13.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 25 | 30 | $18,037 | $2,181 | 12.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 21 | 25 | $23,880 | $1,998 | 8.4% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 26 | 27 | $18,012 | $1,873 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,004 | $1,455 | 72.6% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 13 | 19 | $7,804 | $1,279 | 16.4% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2023 | 40 | 45 | $1,200 | $1,103 | 91.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 18 | 24 | $6,050 | $979.62 | 16.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 15 | 19 | $4,503 | $923.59 | 20.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 13 | 14 | $4,200 | $127.92 | 3.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 247 | $28,354 | $20,010 | 70.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 119 | 313 | $30,380 | $18,924 | 62.3% |
About Dr. Zwade Marshall, M.D
Dr. Zwade Marshall, M.D is a Anesthesiology healthcare provider based in Fayetteville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1750671400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zwade Marshall, M.D has received a total of $29,260 in payments from pharmaceutical and medical device companies, with $3,418 received in 2024. These payments were reported across 879 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($21,784).
As a Medicare-enrolled provider, Marshall has provided services to 3,038 Medicare beneficiaries, totaling 5,743 services with total Medicare billing of $462,134. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Interventional Pain Medicine
- Location Fayetteville, GA
- Active Since 04/14/2011
- Last Updated 02/15/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1750671400
Products in Payments
- Algovita (Device) $5,587
- Senza Spinal Cord Stimulation System (Device) $2,853
- ClosureFast (Device) $2,240
- INTELLIS (Device) $910.15
- INTELLIS ADAPTIVESTIM (Device) $868.32
- PROCLAIM (Device) $735.31
- GENERAL PAIN MANAGEMENT (Device) $734.69
- Proclaim Family of SCS IPGs (Device) $700.70
- Morphabond ER (Drug) $599.43
- RELISTOR (Drug) $589.39
- ZTLido (Drug) $493.97
- Prospera (Device) $488.65
- WaveWriter Alpha Prime 16 (Device) $479.83
- RELISTOR ORAL (Drug) $472.94
- SPRIX (Drug) $439.66
- RESTORE (Device) $420.89
- General - Pain Management (Device) $390.01
- GENERAL - PAIN MANAGEMENT (Device) $355.92
- LORZONE (Drug) $321.65
- Belbuca (Drug) $316.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Fayetteville
Dr. Trevor Van De Water, Md, MD
Anesthesiology — Payments: $3,354
Anesthesiology $3,354
Jason Holt, Md, MD
Anesthesiology — Payments: $2,618
Anesthesiology $2,618
Melissa Lamrissi, Md, MD
Anesthesiology — Payments: $1,978
Anesthesiology $1,978
Dr. Joray Wright, M.d, M.D
Anesthesiology — Payments: $1,972
Anesthesiology $1,972
Dr. Scott Everett, D.o, D.O
Anesthesiology — Payments: $1,146
Anesthesiology $1,146
Dr. Idi Allen, M.d, M.D
Anesthesiology — Payments: $1,041
Anesthesiology $1,041